Literature DB >> 30345286

Intensive Care Therapy for Patients with Advanced Liver Diseases.

Antonios Katsounas1, Ali Canbay1.   

Abstract

Decompensated cirrhosis is characterized by high hospitalization rates and costs, frequent readmissions, and poor short-term survival. Patients admitted to the hospital with acute variceal bleeding and/or hepatic encephalopathy and/or renal dysfunction are at serious risk for developing infection and/or sepsis; in turn, this renders them highly susceptible to the development of multi-system organ failure. The lack of standardized intensive care unit management protocols in patients with cirrhosis along with only few data reports from longitudinal clinical trials makes it difficult for hepatologists and critical care specialists to provide uniform evidence for clinical practice that could safely consolidate favorable outcomes such as lower hospitalization rates and/or mortality. Based on a rigorous online search of the scientific literature as well as a longtime clinical experience of the authors in the field of hepatology and critical care medicine, this work represents a focused effort to elucidate the specific bio-morbidity of advanced liver diseases in relation to the aforementioned challenges in clinical management. Further meta-analyses and/or systematic reviews are needed to enable clinicians to develop more effective strategies to bridge patients with decompensated liver disease to recompensation or liver transplantation.

Entities:  

Keywords:  Acute-on-chronic liver failure, ACLF; Cirrhosis; Critical care; Immune dysfunction; Organ dysfunction

Year:  2018        PMID: 30345286      PMCID: PMC6189546          DOI: 10.1159/000492088

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  76 in total

1.  Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis.

Authors:  Rafael Bañares; Agustín Albillos; Diego Rincón; Sonia Alonso; Mónica González; Luis Ruiz-del-Arbol; Magdalena Salcedo; Luis-Miguel Molinero
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 2.  Haemostatic abnormalities in patients with liver disease.

Authors:  Ton Lisman; Frank W G Leebeek; Philip G de Groot
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

3.  Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.

Authors:  C Francoz; J Belghiti; V Vilgrain; D Sommacale; V Paradis; B Condat; M H Denninger; A Sauvanet; D Valla; F Durand
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

6.  Circulatory function and hepatorenal syndrome in cirrhosis.

Authors:  Luis Ruiz-del-Arbol; Alberto Monescillo; Carlos Arocena; Paz Valer; Pere Ginès; Víctor Moreira; José María Milicua; Wladimiro Jiménez; Vicente Arroyo
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

7.  Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.

Authors:  Javier Sola-Vera; Josep Miñana; Elena Ricart; Montserrat Planella; Begoña González; Xavier Torras; Jose Rodríguez; José Such; Sonia Pascual; Germán Soriano; Miguel Pérez-Mateo; Carlos Guarner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

8.  Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  Javier Fernández; Miguel Navasa; Juan Carlos Garcia-Pagan; Juan G-Abraldes; Wladimiro Jiménez; Jaume Bosch; Vicente Arroyo
Journal:  J Hepatol       Date:  2004-09       Impact factor: 25.083

Review 9.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

10.  Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock.

Authors:  Ming-Hung Tsai; Yun-Shing Peng; Yung-Chang Chen; Nai-Jeng Liu; Yu-Pin Ho; Ji-Tseng Fang; Jau-Min Lien; Chun Yang; Pang-Chi Chen; Cheng-Shyong Wu
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

View more
  3 in total

1.  [Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Authors:  Philipp Kasper; Frank Tacke; Guido Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-10-12       Impact factor: 0.840

2.  [Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Authors:  Philipp Kasper; Frank Tacke; Guido Michels
Journal:  Anaesthesist       Date:  2022-03-31       Impact factor: 1.052

Review 3.  Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.

Authors:  Victor Dong; Constantine J Karvellas
Journal:  JHEP Rep       Date:  2019-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.